128-69-8Relevant articles and documents
Inorganic/organic small molecular semiconductor self-assembly to functional core-shell nanoarchitectures for ultrasensitive chemiresistors to aniline vapor
Wang, Ke,Yang, Hui,Qian, Xuemin,Xue, Zheng,Li, Yongjun,Liu, Huibiao,Li, Yuliang
, p. 11542 - 11547 (2014)
We developed a new method combining the in situ liquid-solid phase reaction and self-assembly in solution to synthesize novel inorganic/organic small molecular semiconductor core-shell nanoparticles of ZnS/PTCDA (ZPNPs). This method is a one-step process which can produce stoichiometric inorganic/organic core-shell nanoparticles and does not introduce any impurity. The film of ZPNPs exhibited an ultrasensitive detection of aniline vapor. The film of ZPNPs can highly selectively distinguish aniline vapor from many volatile organic compounds and water due to the strong synergistic interactions of π-π and hydrogen-bonds between electron donor (aniline) and acceptor (PTCDA) molecules, in which the detection limit was lowered to 100 ppb at room temperature. This journal is the Partner Organisations 2014.
Preparation method and application of novel perylene drug molecule with biological activity
-
, (2018/12/14)
The invention discloses a preparation method and application of a novel perylene drug molecule with the biological activity, and belongs to the technical field of medicine synthesis. According to thekey points of the technical scheme of the preparation method and application of the novel perylene drug molecule, the structural formula of the perylene drug molecule with the biological activity is as shown in the specification, wherein R is O or S. The invention further relates to the preparation method for the novel perylene drug molecule with the biological activity. The perylene drug moleculeprepared through the preparation method has good inhibitory activity on human cervical cancer hHela cells, human breast cancer MDA-MB-231 cells and human liver cancer HepG2 cells, is relatively low in toxicity on human normal cells and has the potential of becoming an anti-tumor drug.
Preparation method of Lumogen Red F300
-
Paragraph 0026; 0034; 0035; 0036; 0042; 0046, (2017/07/20)
The invention relates to Lumogen Red F300, in particular to a preparation method of the Lumogen Red F300. The preparation method comprises the following steps that 1,6,7,12-tetrabromo-3,4,9,10-perylenetetracarboxylic dianhydride is prepared; a 1,6,7,12-tetraphenoxy-3,4,9,10-perylenetetracarboxylic potassium aqueous solution is prepared; and an amination reaction is performed. The preparation method is more scientific and reasonable; and the color fastness is relatively higher, so that the Lumogen Red F300 is close to functional dye.